Merck & Co. raised its first-quarter earnings forecast on Tuesday due to strong sales of its Zocor cholesterol drug and lower-than-expected expenses.
*For more on this story,
read the full Reuters article.
Merck & Co. raised its first-quarter earnings forecast on Tuesday due to strong sales of its Zocor cholesterol drug and lower-than-expected expenses.
*For more on this story,
read the full Reuters article.
Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!
One-Year for Only $99